Sanofi India Ltd - 500674 - Communication Of Deduction Of Tax At Source On Dividend
Dear Sirs Please find enclosed copy of the letter on the above subject sent to the shareholders on 21st July 2022 through email who have registered their email ID with the Company / Depositories. Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has approved issue of duplicate share certificates requests in lieu of the original share certificates reported lost/misplaced, details of which are enclosed: Sanofi India Ltd - 500674 - Board to consider One-time Special Interim Dividend
With reference to the earlier letter dated July 06, 2022 informing about Company''s Board meeting to be held on July 26, 2022, Sanofi India Ltd has now informed BSE that at the said meeting the Board of Directors will also consider declaration of One-time Special Interim Dividend for the year ending December 31, 2022. Sanofi India Ltd - 500674 - Record Date For Interim Dividend
We refer to our earlier letter dated 6th July 2022 informing about Company''s Board meeting to be held on 26th July 2022. We would also like to inform you that at the said meeting the Board of Directors will also consider declaration of One-time Special Interim Dividend for the year ending 31st December 2022. The interim dividend, if declared, shall be paid to the equity shareholders of the Company whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares as on Monday, 8th August 2022 which is the Record Date fixed for the purpose. Sanofi India Ltd - 500674 - Update on board meeting
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2022 ,inter alia, to consider and approve Update We refer to our earlier letter dated 6th July 2022 informing about Company''s Board meeting to be held on 26th July 2022. We would also like to inform you that at the said meeting the Board of Directors will also consider declaration of One-time Special Interim Dividend for the year ending 31st December 2022. The interim dividend, if declared, shall be paid to the equity shareholders of the Company whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares as on Monday, 8th August 2022 which is the Record Date fixed for the purpose. Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has approved issue of duplicate share certificates requests in lieu of the original share certificates reported lost/misplaced, details of which are enclosed: Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed: Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed. Sanofi India Ltd - 500674 - Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On 26Th July 2022
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, 26th July 2022; inter alia to consider the unaudited financial results for the quarter and half year ended 30th June 2022 (Q2). Further to our intimation on 27th June 2022, this is to inform you that as per the "Sanofi India Limited- Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, the trading window of the Company, which was closed from 1st July 2022, for publication of financial results of the Company for the quarter ended 30th June 2022 shall remain closed up to Thursday, 28th July 2022 (inclusive of both days). Sanofi India Ltd - 500674 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the quarter ended 30th June 2022 under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Request you to take the above certificate on record.